We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance

Results: 1-10 of 983

Breaking News: TH v. Novartis - California Supreme Court Recognizes New Tort Duties as Traditional Limits Slide into the Sea
  • Reed Smith LLP
  • USA
  • December 21 2017

We posted our 2017 "Worst 10 decisions" list a day too soon, because the California Supreme Court issued its anticipated decision in TH v. Novartis

Shopping For Standard Food Date Labels
  • Keller and Heckman LLP
  • USA
  • December 6 2017

Your milk says “use by”. Your cheese says “best by”. Those pastries? “Enjoy before.” Supermarket shelves are overflowing with food and beverage

California Passes Drug Transparency Law with Onerous Reporting Requirements for Manufacturers
  • Arent Fox LLP
  • USA
  • October 20 2017

Following in the steps of Maryland and Nevada, California just adopted a comprehensive drug pricing transparency law that will have a significant

New California Law Limits Drug Manufacturer Co-Pay Cards and Other Discounts in California
  • Hogan Lovells
  • USA
  • October 16 2017

In the most recent salvo by states eager to show an effort to contain prescription drug costs, California's governor has signed into law a bill that

San Francisco Ordinance Requires Grocery Chains to Disclose Antibiotic Use in Meat
  • Keller and Heckman LLP
  • USA
  • October 13 2017

For years, FDA, USDA, and various industry stakeholders have sought to tackle public health concerns associated with the use of medically important

The Bank Rejects Fosamax Folly
  • Reed Smith LLP
  • USA
  • October 11 2017

Look what just fell into our lap. Our blogging about the favorable California Risperdal preemption decision last week shook loose from that same case

9th Circuit Delivers Sweet Victory to Soft Drink Advertisers
  • Venable LLP
  • USA
  • October 6 2017

San Francisco found itself in a sticky situation after the Ninth Circuit struck down a city ordinance that would have required soda companies and

Cannabis Prop 65 Liability: Lessons Learned from the Dietary Supplement Industry
  • Wilson Elser
  • USA
  • October 3 2017

The cannabis industry appears to be next on the liability “hit list” under California’s notorious Proposition 65 statute. In June 2017, more than 700

Court Blocks San Francisco Law Requiring Warnings on Soft Drink Ads
  • Keller and Heckman LLP
  • USA
  • September 20 2017

As previously covered on this blog, the City of San Francisco passed legislation in June 2015 that required health warnings to be placed on

California Governor Considers Drug Price Reporting Bill and Ban on Discounts and Rebates for Branded Pharmaceutical Products
  • Cooley LLP
  • USA
  • September 18 2017

The California State Legislature sent two new pharmaceutical pricing measures, S.B. 17 and A.B. 265, to Governor Jerry Brown on September 13th. S.B